Re: AGM - Jan 7, 2016 - Details
in response to
by
posted on
Jan 12, 2016 10:50PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Hi longtimerzen.
I guess I don't know the history very much beyond 8 years ago. Did RVX take over a company to get a TSX listing? I had just assumed they applied for and paid for the TSX listing.
Please let me know the background.
Regards
Toinv